Technology - Serigen Mediproducts Private Limited

Technology

At Serigen, we leverage the unique material science of natural silk proteins to develop cutting-
edge tissue regeneration products.

At Serigen, we leverage the unique material science of natural silk proteins to develop cutting edge tissue regeneration products.

Why Silk?

Silk proteins are protein polymers that are secreted by a variety of species such as spiders, moths, and butterflies. At Serigen, we extract silk proteins from the cocoons of silkworm Bombyx mori, commonly known as the mulberry silkworm. Here are some reasons why we chose Silk as the building block of our diverse range of biomedical products

Our Technology

At Serigen, we have developed innovative processing protocols to transform silk threads into a solution that can be structured and shaped into various forms to create a varied range of biomedical products.

At the heart of Serigen’s technology platform is a mastery of the materials science of silk-based polymers and a deep understanding of biomedical materials. With our patented technology, we can leverage the unique properties of silk to develop a wide range of medical devices to serve the unmet clinical needs of diverse patient communities.

Technology Grounded In Science

“Silk Fibroin porous micro-particle scaffolds”, Anuya Nisal*, Raeesa Sayyad, Prachi Dhavale, Bhakti Khude, Vidhyashri Mapare, Rucha Deshpande, Swati Shukla, Premnath Venugopalan, Scientific Reports, 2018, 8:7235

“Silk Fibroin Microparticle Scaffold for Use in Bone Void Filling: Safety and Efficacy Studies”, Rucha Deshpande, Swati Shukla*, Amod Kale, Narendra Deshmukh, Anuya Nisal, and Premnath Venugopalan, ACS Biomaterials Science & Engineering, 2022

“Silk fibroin and ceramic scaffolds: Comparative in vitro studies for bone regeneration” Rucha Deshpande, Swati Shukla*, Raeesa Sayyad, Shalmali Salunke, Anuya Nisal*, Premnath Venugopalan, Bioengineering & Translational Medicine. 2021; e10221

Technology Protected By Patents

Highly crystalline spherical silk fibroin micro-particles and a process for preparation thereof. Granted in India, Europe & USA

Silk based Porous Scaffold and a process for the preparation thereof. Granted in India, Europe and Japan

Ravi Sarangpani

Consultant – Medical Devices

Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.

Consultant, Medical Devices

Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.

Adler Mediequip, A Smith & Nephew Company. Director NPD
2014 – 2019

Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.

Adler Mediequip. VP – Development & Quality Management
2010 – 2014

Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.

Sushrut Surgicals – A Sushrut-Adler Group Company
2001 – 2010 VP Marketing and Sales
1993 – 2000 Marketing Manager

Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.